Depressive Symptoms clinical trials

Explore recruiting depressive symptoms clinical trials.

Recruiting depressive symptoms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Depressive Symptoms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Targeting inflammation in depression using Minocycline: a patient stratification approach using peripheral inflammatory biomarkers and MRI

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

The Acute and Long-term Impact of Support in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

ERPPAD - Efficacy in Relapse Prevention: Psilocybin in Alcohol use disorder with Depressive symptoms

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Brain effects of hormonal contraceptives. A randomized, double-blind, longitudinal study comparing two combined oral contraceptives (Estetrol/drospirenone vs ethinylestradiol/levonorgestrel).

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A Double-blind, Randomized, Psychoactive Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine 84 mg in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder in Adolescent Participants with Acute Suicidal Ideation or Behavior

Italy, Hungary, Spain, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

AIDA-DEP - Accelerated Intermittent theta-burst stimulation with D-cycloserine Augmentation for DEPression - a multicenter, randomized, placebo-controlled, double-blind clinical trial

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Depressive Symptoms trials by city

Depressive Symptoms in Toronto Depressive Symptoms in Vancouver Depressive Symptoms in Montreal Depressive Symptoms in Calgary Depressive Symptoms in Edmonton Depressive Symptoms in Ottawa Depressive Symptoms in Winnipeg Depressive Symptoms in Quebec City Depressive Symptoms in Hamilton Depressive Symptoms in Kitchener Depressive Symptoms in London Depressive Symptoms in Halifax Depressive Symptoms in New York Depressive Symptoms in Los Angeles Depressive Symptoms in Chicago Depressive Symptoms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease